SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-061538
Filing Date
2024-03-07
Accepted
2024-03-07 08:45:01
Documents
18
Period of Report
2024-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d765460d8k.htm   iXBRL 8-K 40776
2 EX-10.2 d765460dex102.htm EX-10.2 95278
3 EX-10.1 d765460dex101.htm EX-10.1 274149
4 EX-99.1 d765460dex991.htm EX-99.1 9898
8 GRAPHIC g765460g0307103108727.jpg GRAPHIC 4263
  Complete submission text file 0001193125-24-061538.txt   648858

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20240306.xsd EX-101.SCH 2843
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20240306_lab.xml EX-101.LAB 17993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20240306_pre.xml EX-101.PRE 11256
19 EXTRACTED XBRL INSTANCE DOCUMENT d765460d8k_htm.xml XML 3640
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 24728269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)